Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration
Sleiman, S.F.; Berlin, J.; Basso, M.; S.Karuppagounder, S.; Rohr, J.; Ratan, R.R. Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration. Pharmaceuticals 2011, 4, 1183-1195. https://doi.org/10.3390/ph4081183
Sleiman SF, Berlin J, Basso M, S.Karuppagounder S, Rohr J, Ratan RR. Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration. Pharmaceuticals. 2011; 4(8):1183-1195. https://doi.org/10.3390/ph4081183
Chicago/Turabian StyleSleiman, Sama F., Jill Berlin, Manuela Basso, Saravanan S.Karuppagounder, Jürgen Rohr, and Rajiv R. Ratan. 2011. "Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration" Pharmaceuticals 4, no. 8: 1183-1195. https://doi.org/10.3390/ph4081183